A21T (p.Ala21Thr) variant of TGFBR2 (TGF-beta receptor type-2)

A21T (p.Ala21Thr) in TGFBR2 (TGF-beta receptor type-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Familial thoracic aortic aneurysm and aortic dissection; Diabetic retinopathy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes population frequency data and structural context.

A21T (p.Ala21Thr) variant details